outcom
pregnanc
affect
sever
acut
respiratori
syndrom
maxwel
c
hong
sf
sermer
recent
worldwid
outbreak
sever
acut
respiratori
syndrom
sar
implic
develop
atyp
pneumonia
human
sever
case
report
pregnant
women
hong
kong
isol
case
report
singapor
canada
recent
microbiolog
evid
point
novel
coronaviru
spread
via
contact
droplet
transmiss
limit
data
avail
regard
epidemiolog
natur
histori
diseas
publish
inform
regard
outcom
associ
pregnanc
given
appar
virul
sar
organ
decreas
immun
associ
pregnanc
diseas
progress
pregnant
women
may
compar
sever
type
viral
pneumonia
result
high
matern
perinat
morbid
mortal
rate
given
signific
matern
perinat
morbid
mortal
viral
pneumonia
pregnanc
sar
may
impos
greater
risk
pregnant
compar
individu
care
pregnant
women
also
pose
sever
question
regard
labour
deliveri
manag
well
protect
health
care
provid
report
outcom
women
diagnos
sar
pregnanc
collabor
centr
canada
hong
kong
clinic
present
sar
pregnant
women
describ
sixti
percent
pregnant
women
sar
requir
intub
thirti
percent
patient
deliv
preterm
rate
caesarean
section
three
matern
death
report
also
describ
centr
approach
labour
deliveri
suit
organis
view
care
affect
pregnant
individu
well
manag
expos
neonat
pregnanc
complic
heart
diseas
review
contemporari
canadian
experi
sermer
colman
j
siu
ss
physiolog
adapt
pregnanc
potenti
worsen
prognosi
women
whose
pregnanc
complic
heart
diseas
comprehens
systemat
approach
risk
identif
desir
abil
predict
subgroup
women
particularli
increas
risk
complic
enhanc
obstetr
care
provid
popul
retrospect
review
pregnanc
associ
heart
diseas
undertaken
three
toronto
teach
institut
cours
pregnanc
complet
gestat
complic
advers
cardiovascular
event
congest
heart
failur
arrhythmia
stroke
poor
matern
function
class
cyanosi
myocardi
dysfunct
left
heart
obstruct
prior
arrhythmia
prior
cardiac
event
predict
matern
cardiac
complic
prior
predictor
convert
point
score
point
score
risk
patient
develop
advers
cardiac
event
respect
canadian
prospect
multicentr
studi
allow
valid
simplif
predict
rule
studi
centr
prospect
recruit
patient
complet
gestat
similar
factor
identifi
predict
advers
cardiac
event
addit
neonat
complic
pregnanc
associ
poor
function
class
cyanosi
left
heart
obstruct
anticoagul
smoke
multipl
gestat
sampl
prospect
cohort
pregnanc
compar
match
pregnanc
underli
heart
diseas
neonat
complic
rate
higher
studi
group
compar
control
veru
respect
highest
neonat
complic
rate
seen
gravida
underli
heart
diseas
previous
identifi
cardiac
risk
factor
extrem
reproduct
age
obstetr
risk
factor
smoke
receiv
anticoagul
matern
neonat
morbid
significantli
increas
gravida
heart
diseas
although
mortal
low
factor
place
mother
neonat
risk
identifi
prior
pregnanc
allow
inform
counsel
develop
manag
plan
cardiac
diseas
pregnanc
indian
experi
bhatla
n
lal
behera
g
kriplani
mittal
kumar
mukhpoadhyay
agarw
n
yadav
r
talwar
kk
evalu
matern
fetal
outcom
pregnanc
complic
cardiac
diseas
develop
countri
retrospect
analysi
carri
pregnanc
women
cardiac
diseas
deliv
week
gestat
june
decemb
tertiari
care
centr
rheumat
heart
diseas
n
isol
mitral
stenosi
n
predomin
cardiac
problem
septal
defect
common
form
congenit
heart
diseas
n
women
diagnosi
cardiac
diseas
made
pregnanc
cardiac
complic
note
fetal
complic
pregnanc
patient
new
york
heart
associ
nyha
class
n
fewer
matern
complic
babi
higher
birthweight
nyha
class
n
cardiac
intervent
perform
prior
pregnanc
patient
rheumat
heart
diseas
ptmccmv
valv
replac
vr
matern
fetal
outcom
better
patient
prosthet
valv
n
major
remain
nyha
class
cardiac
intervent
safe
carri
pregnanc
women
ptmc
seven
cmv
one
vr
two
one
develop
congest
cardiac
failur
labour
none
newborn
women
receiv
anticoagul
congenit
malform
rheumat
heart
diseas
predomin
type
patient
nyha
class
better
matern
fetal
outcom
nyha
class
surgic
correct
cardiac
lesion
prior
pregnanc
associ
better
pregnanc
outcom
pregnant
women
prosthet
valv
toler
pregnanc
well
chip
pilot
trial
control
hypertens
pregnanc
studi
work
progress
chip
trial
determin
less
tight
vs
tight
control
hypertens
pregnanc
decreas
advers
perinat
outcom
without
increas
matern
risk
first
chip
pilot
trial
determin
complianc
trial
intervent
differenti
bp
control
chip
pilot
recruit
women
per
arm
intern
year
inclus
dbp
mmhg
due
gestat
hypertens
live
fetu
es
week
exclus
sever
hypertens
proteinuria
contraind
either
arm
pregnanc
prolong
known
major
fetal
anomali
treatment
randomis
either
less
tight
control
target
dbp
mmhg
tight
control
target
dbp
mmhg
bp
intervent
less
tight
control
bp
therapi
stoppeddecreas
dbp
mmhg
startedincreas
dbp
mmhg
dbp
mmhg
chang
tight
control
bp
therapi
stoppeddecreas
dbp
mmhg
startedincreas
dbp
mmhg
dbp
mmhg
chang
group
labetalol
prefer
otherwis
usual
care
data
collect
obstetr
cointervent
outcom
primari
mean
dbp
week
secondari
clinician
complianc
intervent
women
satisfact
care
outcom
main
chip
includ
seriou
perinat
complic
birthweight
percentil
primari
seriou
matern
complic
secondari
standardis
bp
measur
dbp
bp
therapi
record
diari
week
trial
meet
women
review
diari
bp
manag
dbp
measur
independ
outcom
assess
deliveri
admiss
women
complet
questionnair
view
cihr
fund
recruit
interest
centr
contact
l
mage
lmage
cwbcca
chip
studi
group
matern
puls
pressur
sever
earli
onset
steyn
w
assess
manag
hypertens
pregnanc
depend
systol
blood
pressur
sbp
diastol
blood
pressur
dbp
rel
littl
publish
puls
pressur
assess
characterist
matern
puls
pressur
pp
sever
earli
onset
pe
blood
pressur
mother
sever
pe
week
gestat
manag
expectantli
also
measur
everi
min
altern
day
pregnanc
valid
spacelab
ambulatori
monitor
result
avail
manag
clinician
women
manag
accord
department
polici
mean
pp
measur
obtain
women
mmhg
pp
correl
significantli
sbp
r
p
dbp
r
p
mean
arteri
pressur
map
r
p
correl
pp
sbp
remain
signific
pp
valu
correl
pp
dbp
signific
upper
quartil
pp
consid
pp
also
significantli
influenc
pariti
multipara
mmhg
primipara
mmhg
p
medic
use
gestat
age
ga
ga
week
mmhg
ga
week
mmhg
p
mean
pp
higher
night
vs
p
mean
sbp
mean
map
significantli
higher
upper
quartil
pp
compar
lower
quartil
vs
mmhg
vs
mmhg
respect
dbp
decreas
mmhg
vs
mmhg
puls
pressur
chang
women
sever
compat
increas
arteri
stiff
seem
influenc
sbp
dbp
implic
find
investig
two
step
screen
fetal
growth
restrict
wilson
c
baker
l
ni
bhuinneain
wallac
em
object
elev
matern
serum
hcg
abnorm
uterin
arteri
doppler
flow
velocimetri
waveform
associ
advers
pregnanc
outcom
neither
test
demonstr
adequ
util
predict
marker
set
assess
predict
capac
two
step
screen
process
method
institut
women
unexplain
elev
hcg
level
mom
offer
uterin
arteri
doppler
assess
week
gestat
audit
util
practic
review
preval
advers
outcom
gestat
hyertens
intrauterin
growth
restrict
iugr
preterm
birth
result
women
serum
hcg
underw
doppler
studi
uterin
arteri
flow
veloc
waveform
ut
afvw
notch
ut
afvw
afford
better
predict
util
outcom
resist
index
ri
alon
combin
notch
composit
advers
outcom
gestat
hypertens
birthweight
centil
preterm
deliveri
week
presenc
uterin
notch
alon
sensit
specif
posit
likelihood
ratio
neg
likelihood
ratio
identif
sever
fetal
growth
restrict
centil
presenc
notch
offer
sensit
specif
posit
likelihood
ratio
neg
likelihood
ratio
conclus
identif
uterin
arteri
notch
doppler
ultrasound
compon
surveil
women
unexplain
elev
hcg
level
significantli
improv
predict
sever
iugr
treatment
deep
venou
thrombosi
heparin
pregnanc
uland
kaaja
r
lmw
heparin
shown
least
effect
unfraction
uf
heparin
treatment
deep
venou
thrombosi
dvt
subject
lmw
heparin
shown
safe
use
pregnanc
cross
placenta
use
mainli
thromboprophylaxi
pregnanc
rare
treatment
acut
dvt
pregnant
women
prospect
observ
studi
compar
effect
safeti
lmw
heparin
dalteparin
versu
uf
heparin
initi
treatment
first
week
dvt
pregnanc
confirm
dvt
ultrasonographi
women
treat
uf
heparin
iuday
mean
women
dalteparin
iuday
mean
day
thereaft
women
given
treatment
dose
anoth
week
dose
gradual
decreas
kept
high
prophylact
dose
deliveri
one
patient
dalteparin
group
recurr
dvt
week
start
treatment
differ
observ
group
symptom
bleed
complic
pregnanc
deliveri
result
indic
lmw
heparin
effect
safe
uf
heparin
first
week
treatment
lmw
heparin
advantag
easili
administ
laboratori
control
requir
metastat
paraganglioma
pregnanc
case
report
success
pregnanc
outcom
adair
ellwood
yip
carney
g
kecsk
z
tucker
k
metastat
rare
condit
recent
shown
sometim
due
autosom
dominantli
transmit
mutat
sdhb
c
gene
patient
year
old
present
recurr
abdomin
pain
year
histori
hypertens
ct
scan
demonstr
mass
mibg
scan
reveal
three
foci
surgic
resect
tumour
follow
histolog
confirm
metastat
parganglioma
subsequ
develop
addit
lesion
thorax
left
hip
treat
abl
mibg
therapi
becam
inadvert
pregnant
earli
underw
mibg
ct
scan
earli
pregnanc
prior
diagnosi
seen
antenat
care
week
counsel
risk
continu
pregnanc
well
risk
fetu
blood
pressur
medic
initi
phenoxybenzamin
chang
labetalol
mg
bd
week
good
control
ultrasound
scan
week
normal
corticosteroid
administr
underw
elect
caesarean
section
week
allow
mibg
abl
therapi
take
place
infant
femal
weigh
g
requir
ventil
hyalin
membran
diseas
case
illustr
success
pregnanc
outcom
woman
seriou
potenti
lethal
condit
particular
unknown
fetal
risk
teratogen
genet
well
potenti
seriou
matern
risk
sever
hypertens
diseas
progress
multidisciplinari
approach
manag
essenti
ingredi
case
visual
disturb
dhanjal
mk
anthoni
j
case
report
shown
visual
disturb
retin
detach
aim
studi
identifi
natur
ophthalmolog
abnorm
patient
persist
visual
disturb
beyond
deliveri
women
visual
disturb
persist
beyond
first
postnat
day
groot
schuur
hospit
year
period
underw
formal
ophthalmolog
review
women
requir
ophthalmolog
assess
persist
visual
disturb
postpartum
women
sever
least
proteinuria
mean
highest
antenat
blood
pressur
women
abnorm
identifi
fundoscopi
ct
scan
seventeen
women
exud
serou
retin
detach
bilater
eight
women
elshnig
spot
ischaem
infarct
choroid
elshnig
spot
retin
detach
three
women
infarct
identifi
ct
scan
one
patient
cortic
blind
one
optic
atrophi
fundoscop
defin
retin
abnorm
occur
women
visual
disturb
persist
beyond
first
postnat
day
common
abnorm
exud
serou
retin
detach
usual
revers
elshnig
spot
manifest
choroid
ischaemia
infarct
cortic
blind
optic
atrophi
also
occur
improv
hospit
manag
pregnanc
induc
hypertens
use
failur
mode
effect
analysi
blackburn
ca
powri
ro
sauv
n
sung
j
eidson
e
henri
k
like
aspect
healthcar
manag
pregnanc
induc
hypertens
pih
hospit
subject
error
ineffect
conduct
process
improv
strategi
known
failur
mode
effect
analysi
fmea
identifi
potenti
problem
improv
manag
pih
hospit
octob
multidisciplinari
team
form
perform
fmea
review
aspect
process
manag
pih
referr
hospit
discharg
activ
identifi
potenti
problem
failur
mode
defin
caus
surmis
effect
failur
occur
numer
score
assign
likelihood
failur
occurr
sever
effect
score
multipli
report
risk
prioriti
number
rpn
failur
mode
solut
monitor
plan
develop
address
failur
mode
highest
rpn
four
top
area
need
improv
accuraci
blood
pressur
measur
ii
patient
educ
iii
evalu
proteinuria
iv
assess
treatment
sever
hypertens
initi
chang
implement
monitor
process
describ
fmea
use
process
identifi
implement
institut
chang
regard
manag
pih
process
may
serv
model
initi
institut
similar
need
liver
transplant
pregnanc
morton
ap
fertil
return
within
month
success
liver
transplant
june
approxim
liver
transplant
perform
australian
women
potenti
age
cours
outcom
seven
pregnanc
four
liver
transplant
recipi
describ
four
pregnanc
three
mother
complic
intrahepat
cholestasi
one
pregnanc
complic
acut
chronic
renal
failur
requir
dialysi
literatur
pregnanc
outcom
liver
transplant
recipi
manag
acut
chronic
renal
failur
pregnanc
discuss
review
current
clinic
practic
outcom
relat
bile
acid
measur
obstetr
cholestasi
thein
brewster
j
hirst
horner
j
recent
diagnosi
obstetr
cholestasi
oc
made
made
basi
clinic
observ
appar
consider
inaccuraci
howev
condit
increas
risk
perinat
mortal
matern
morbid
current
treatment
ursodeoxychol
acid
reduc
bile
acid
level
blood
involv
use
medic
said
potenti
teratogen
licens
use
pregnanc
henc
extrem
desir
abl
identifi
accuraci
case
realli
need
treatment
accordingli
attempt
identifi
suitabl
local
protocol
manag
carri
review
pregnant
women
serum
total
bile
acid
level
measur
whole
identifi
biochemistri
databas
individu
case
note
review
initi
review
carri
women
serum
bile
acid
level
measur
one
occas
last
quarter
total
test
perform
case
period
eighteen
case
found
level
within
normal
limit
four
requir
ursodeoxychol
acid
labour
induc
three
women
approach
term
remain
symptomat
serum
bile
acid
level
slightli
rais
remain
six
case
resolv
spontan
rais
initi
bile
acid
level
fall
within
normal
subsequ
test
shall
present
outcom
review
case
refer
normal
rang
basi
shall
make
recommend
protocol
diagnosi
manag
oc
view
reduc
perinat
mortal
matern
morbid
serum
glutathion
alpha
index
hepatocellular
damag
rais
week
gestat
women
develop
obstetr
cholestasi
girl
j
dann
kenyon
seed
p
c
williamson
c
shennan
tribe
r
statement
purpos
glutathion
alpha
highli
sensit
earli
indic
hepatocellular
damag
determin
longitudin
studi
whether
use
marker
obstetr
cholestasi
oc
whether
distinguish
oc
pruritu
gravidarum
pg
statement
method
serum
measur
women
develop
oc
median
gestat
week
rang
ursodeoxychol
acid
exclud
pg
normal
pregnanc
serum
sampl
least
three
time
week
gestat
deliveri
summari
result
increas
gestat
oc
group
group
significantli
greater
week
gestat
normal
pregnanc
pg
oc
group
highli
signific
correl
p
level
alanin
spearman
rank
correl
r
total
bile
acid
r
relat
sever
pruritu
r
p
concentr
sensit
ci
specif
ci
posit
predict
valu
ci
neg
predict
valu
ci
likelihood
ratio
posit
test
differenti
oc
pg
conclus
first
seri
measur
oc
pg
use
marker
liver
dysfunct
distinguish
women
oc
pg
unusu
case
pre
eclampsia
sangal
interact
case
present
abstract
avail
